P08.41 The metabolic effect of bevacizumab in mutant IDH1 glioma cells assessed by NMR spectroscopy

Introduction: Malignant gliomas are rapidly growing and invasive tumours that secrete vascular endothelial growth factor (VEGF) to stimulate tumour angiogenesis. Bevacizumab by neutralizing the biological activity of VEGF normalizes tumour vasculature, and inhibits further angiogenesis, thereby inhi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Mesti, T., Bouchemal, N., Banissi, C., Triba, M., Marbeuf-Gueye, C., Le Moyec, L., Ocvirk, J., Savarin, P., Carpentier, A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2017
Pynciau:
POSTER PRESENTATIONS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463854/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.230
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg